Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
about
Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analoguesEnzymology of purine and pyrimidine antimetabolites used in the treatment of cancerTreating refractory leukemias in childhood, role of clofarabinePhysiological and pathological implications of 5-hydroxymethylcytosine in diseasesFifty years of melphalan use in hematopoietic stem cell transplantationTangled up in knots: structures of inactivated forms of E. coli class Ia ribonucleotide reductaseX-ray Scattering Studies of Protein Structural Dynamics.Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 studyPhase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.Polyadenylation inhibition by the triphosphates of deoxyadenosine analogues.Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS.The chemoenzymatic synthesis of clofarabine and related 2'-deoxyfluoroarabinosyl nucleosides: the electronic and stereochemical factors determining substrate recognition by E. coli nucleoside phosphorylases.Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.Clofarabine: past, present, and future.A fluorimetric readout reporting the kinetics of nucleotide-induced human ribonucleotide reductase oligomerization.Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunitNovel PET probes specific for deoxycytidine kinase.DNA repair mechanisms in cancer development and therapyPreclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study.New trends in nucleoside biotechnologyValproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.Clofarabine targets the large subunit (α) of human ribonucleotide reductase in live cells by assembly into persistent hexamersStratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosidesFrench "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia.Studies toward the oxidative and reductive activation of C-S bonds in 2'-S-aryl-2'-thiouridine derivatives.Acute myeloid leukaemia: optimal management and recent developments.Oral clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.Fluorinated Nucleosides: Synthesis and Biological ImplicationCladribine and Fludarabine Nucleotides Induce Distinct Hexamers Defining a Common Mode of Reversible RNR Inhibition.Hypermutation of DPYD Deregulates Pyrimidine Metabolism and Promotes Malignant Progression.Inhibition of ATP synthase by chlorinated adenosine analogue.Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.Older patients with acute myeloid leukemia.New nucleoside analogs for patients with hematological malignancies.Clofarabine for myelodysplastic syndromes.Clofarabine in pediatric acute leukemia: current findings and issues.The prototypic class Ia ribonucleotide reductase from Escherichia coli: still surprising after all these years.
P2860
Q24629752-73C8AF06-3F2B-491E-841E-C8BD4A727830Q24642847-29275304-1F06-440A-B8BB-74897ABF5C99Q24647279-EED4B620-27DF-4AB9-BC2B-3E1F6F6F66ACQ26749375-EAA14BDE-E65C-433F-8041-47DAD8E36028Q26824498-463E969E-C7B4-486D-B9BE-EE7058D95268Q27681351-2630BE7B-2AC2-4EA0-B53D-7F5E8883CA6FQ30101114-3F9C5084-2188-4BEF-B6EC-BE6C816E9F63Q30243925-412BE301-41A6-456E-8448-FDB6FEC23D9FQ33405103-E7050F78-D60B-46D3-9A8A-30D9903DED58Q33431558-17BC2713-973B-4CAD-9C0D-7D9AE3A6712EQ33721126-5A47E305-3A6E-403D-9AB6-C00D3EB1B623Q33949932-96094445-7F03-463E-8732-C3C8C03F6353Q34082241-0493F30A-5027-428A-9F08-CE6BE47BB2BEQ34159634-0F488591-8B6C-4251-9515-216838BF9CCEQ34267853-B2F9DF99-9101-4A62-9D5F-9661D4ADB4DBQ34686726-C1B69DCD-1BA0-4655-922B-A9610C1E408DQ34740945-4352E092-7A48-4C80-84E3-610F6C1C7387Q35049193-EBCDFC53-8005-40CF-960F-CC22A2023976Q35059531-BD6DAF8E-94D7-4E9C-BCB3-FF6392B2CE81Q35531287-94026EAE-AD29-48B3-BACF-A8B559DA651EQ35572057-64EFFC07-FDF3-4C1F-997D-8698E20EB181Q35944327-94B7A75D-8D6A-4613-A753-B6F5E876EE17Q36094977-23A335E4-F9C5-4339-AA05-25BBCD154CB6Q36128479-C0A32465-19E3-4907-8EDE-E7C34D589F03Q36201693-EFDA5C97-A1F0-4514-9096-D0E77B1CD7B0Q36374005-63587F8A-EA20-4837-A94D-6D1BB125132CQ36689775-7EDA58BE-9C40-4E2C-AFF8-C8828282C4B2Q36724814-815E21B0-8ADE-4BCA-B784-21A10FEB0AF5Q36914091-0BBF10C4-D7C1-441A-B97C-796B64F9C8E6Q36915178-BE2DB39F-BD47-4822-997D-D230DDBE3620Q36974059-E9B3070D-F7EA-47B4-A6D4-1D5271DD4053Q37099024-E9CF8034-E263-4C7E-9211-809FE4047084Q37258328-62E3EBFD-ADAC-4490-B013-4C096A0CEC78Q37391304-B0C1972C-C3CC-4876-93DC-90AF73AD08D0Q37424784-0A02BBE0-BD93-4938-B3BE-AA6EAB0907ADQ37810969-44F25FAD-2743-4451-A275-412A4FB8E9BBQ37841589-BF2B585D-04D7-4F8B-9466-F1FCF0CB70A7Q37876909-9C1E31D3-4EF5-480C-9599-19042B8CE517Q37987061-8635D500-94A4-448D-A103-6503A6BACAB0Q38012192-DDB5C145-0060-4D34-B9F0-B4E46629B93D
P2860
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@ast
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@en
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@nl
type
label
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@ast
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@en
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@nl
prefLabel
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@ast
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@en
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@nl
P2093
P356
P1476
Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
@en
P2093
John A Secrist
Katherine Stephenson
Larry Arthaud
Peter L Bonate
Steve Weitman
William R Cantrell
P2888
P304
P356
10.1038/NRD2055
P577
2006-10-01T00:00:00Z